Immunotherapy: Clinical Trials

3 trials for Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases
Serplulimab combined with bevacizumab and first-line chemotherapy - Non-small Cell Lung Cancer Stage II, Bevacizumab
Phase 2 / Phase 3CompletedSun Yat-sen University402023-05-142024-11-13
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
xintilimab injection, Control - Neoadjuvant Chemoradiation Therapy, Rectal Cancer
Phase 2 / Phase 3CompletedChanghai Hospital2012022-10-012026-01-02
Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy
specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot) - Immunotherapy
Phase 3CompletedJohann Wolfgang Goethe University Hospital342004-05-012007-10-05

Narrower conditions

Asthma (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Rectal Neoplasms (1)

Broader conditions

Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Brain Diseases (1)  ·  Bronchial Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)

Interventions

Bevacizumab (1)  ·  Novo-Helisen Depot (1)

Sponsors

Changhai Hospital (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  Sun Yat-sen University (1)

Countries

China (2)  ·  Germany (1)

Top investigators

Stefan Zielen, M.D., Ph.D. (1)

Results publications

PMID 37709314